Venture or growth equity
For companies funding product and commercial milestones without scheduled repayment.
Institutional, strategic and growth equity for software, AI, digital infrastructure and deep-technology companies raising USD 5m or more.

The strongest technology financing cases connect product differentiation to commercial proof, efficient customer growth and a milestone plan that the requested capital can fund.
We begin with the commercial objective, the amount and timing of capital, the evidence available and the authority to run the transaction. The resulting route can then be tested against realistic investor, lender or buyer criteria.
The route is selected after reviewing cash flows, control, security, dilution, timing and counterparty appetite.
For companies funding product and commercial milestones without scheduled repayment.
For companies where industry participation accelerates distribution, infrastructure or market access.
For negotiated milestone, preference or conversion terms suited to the risk profile.
The sequence is adapted to transaction readiness, confidentiality and the selected capital route.
Public mandate summaries are current at the website build date. Detailed information is available following counterparty qualification.
Matchpoint considers technology capital raises from USD 5m upwards across software, AI, digital infrastructure, deep technology and related verticals.
Relevant metrics can include recurring revenue, retention, gross margin, customer concentration, sales efficiency, deployment economics, runway and milestone delivery.
A pre-revenue company requires strong technical validation, protected intellectual property, credible milestones, a suitable investor universe and a clearly funded commercialisation path.
Yes. Corporates, infrastructure groups and technology partners may be relevant where their commercial objective aligns with the company's financing plan.
Share your company, transaction type and approximate ticket size. A partner will review the fit for a USD 5m+ mandate.